Figure S7 from CRISPR–Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer

Q: What type of study is this?

This is a Experimental Study study.

Nikola Knoll; Sarah Masser; Blanka Bordas; Richard Y. Ebright; Guangyan Li; Devishi Kesar; Eliana Destefanis; Nicholas Kania; Diego J. Rodriguez; Jayu Jen; Sydney E. Zagar; Caleb Mensah; Zixin Chen; Samuel J. Moffitt; Erhumuoghene M. Enakireru; Yao He; Baomou Feng; Mira K. Chokshi; Cyrus Y. Jin; Srivatsan Raghavan; William R. Sellers; Kathleen M. Mulvaney

doi:10.1158/0008-5472.30125727

Key Points

Colony formation assays reveal significant tumor reduction with drug combinations in MTAP-deleted cancer cell lines.
The combination of ulixertinib and MRTX1719 effectively inhibits growth across multiple drug concentrations.
Observational analysis using colony formation assays assessed the efficacy of combining an ERK1/2 inhibitor and a PRMT5 inhibitor.
Findings suggest potential therapeutic strategies for targeting MTAP-deleted cancers; further validation in clinical settings is necessary.

Implication

Colony formation assays show effectiveness of ulixertinib and MRTX1719 in MTAP-deleted cancer cells, highlighting potential synergies.

Abstract

Figure S7. Colony formation assays of five cell lines treated with ERK1/2 inhibitor ulixertinib, PRMT5 inhibitor MRTX1719, or the combination across all drug concentrations are shown.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Knoll et al. (2025) studied this question.

synapsesocial.com/papers/68d4508931b076d99fa588d4 https://doi.org/10.1158/0008-5472.30125727

View at Publisher

Ask AI

Bookmark

Share

Figure S7 from CRISPR–Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Figure S7 from CRISPR–Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading